SUMMARY Faecal bile acids and neutral sterols of cholesterol origin were decreased in patients with chronic liver disease, while urinary bile acids were constantly, but never greatly, increased. Thus, production of cholesterol and its conversion to bile acids was decreased in these patients. Faecal fat was only slightly increased, even in cases with a very low bile salt output, but it was negatively correlated with faecal bile acids. The reduced capacity of these patients to synthesize bile acids was shown by the fact that cholestyramine treatment, although it decreased urinary bile acids, increased faecal bile acids only slightly. The resin constantly increased faecal neutral sterols, while the increase of faecal fat was insignificant. Thus, the absorption of fats, as compared with that of sterols, was less strongly reduced by interruption of the enterohepatic circulation of bile salts. In one cirrhotic patient markedly increased faecal bile acids apparently caused cholerrhoeic diarrhoea, which was easily controlled with cholestyramine. The latter consistently increased elimination of cholesterol in cirrhotic patients, but serum chole3terol was not consistently decreased, and in these patients, in contrast to the control subjects, it was difficult to detect changes in cholesterol synthesis with the acetate-mevalonate test and serum methyl sterols.
In liver cirrhosis, though intraluminal micellar solubilization of lipids is frequently impaired (Badley, Murphy, Bouchier, and Sherlock, 1970; Siurala, 1967, 1971) , fat malabsorption is usually only mild or moderate (Losowsky and Walker, 1969) . The absence of the micellar phase does not necessarily lead to gross steatorrhoea, presumably owing to the relatively effective absorption of free fatty acids along the whole small intestine (Hofmann, 1966; Morgan and Borgstrom, 1969) . Some workers have suggested that impaired micelle formation in liver cirrhosis is due to impaired bile salt production, resulting in a low intestinal concentration of bile salts during fat digestion (Badley et al, 1970; Siurala, 1967, 1971) . Others claim that bile salt production is normal in liver cirrhosis and that neither deficient output nor low intestinal concentration of bile salts are responsible for the steatorrhoea in this disease (Turnberg and Grahame, 1970; Bode, Goebell, and Kehl, 1971) . Although Blum and Spritz (1966) studied the turnover rate and pool size of 14C-cholic Received for publication 28 June 1972. acid, apart from some preliminary studies (Miettinen, 1970 (Miettinen, , 1971a , no information is available on the capacity of cirrhotic subjects to produce bile acids under basal conditions and during interruption of the enterohepatic circulation. In the present investigation bile salt production was measured directly by determining faecal and urinary excretion before and during cholestyramine treatment, faecal fat and faecal nautral sterols being taken as indicators of lipid absorption and of bile salt deficiency. Compensatory changes in cholesterol synthesis to balance for cholestyramine-induced loss of cholesterol as bile acids and sterols was measured with the acetatemevalonate test and serum methyl sterols (Miettinen, 1970; 1971b) .
Materials and Methods

PATIENTS
The material (Table I) Table I Clinical and laboratory observations on the patients studied ASAT = asparagine aminotransferase; ALAT = alanine aminotransferase; AFOS = alkaline phosphatase (normal values <50 I,u/ml). or in connexion with laparoscopy or laparotomy. None of the patients with chronic hepatitis had Au-antigen in blood or antinuclear antibodies. At the time of study, liver function was relatively well compensated in most of the patients, none of whom exhibited signs of hepatic coma. Case 15 was comatose when admitted four weeks before the study. From the liver function tests available (see Table I ), increased alkaline phosphatase was assumed to signify biliary obstruction. Therefore, the series was divided into two groups according to whether alkaline phosphatase was normal, below 50 international (I) ,uU/ml (cases 1-7), or raised above 50 I ,uU/ml (cases 8-15).
STUDIES
The patients were placed on a low-cholesterol (125 mg/2 400 kcal) solid food diet, containing 80 g of fat (equal amounts of lard and soybean oil) per 2400 kcal. Unabsorbable Cr2O3 and ,-sitosterol (containing, according to analysis, 85 % ,-sitosterol), 600 mg of each divided into three daily doses, were given so that corrections could be made respectively for faecal flow and degradation of cholesterol during intestinal transit (Grundy, Ahrens, and Salen, 1968 (Miettinen, 1970 (Miettinen, , 1971b (Miettinen, 1970 (Miettinen, , 1971b . Therefore, non-esterified methyl sterols and free cholesterol were also measured before and at the end of cholestyramine treatment.
Since there was no justification for performing sterol balance studies, acetate-mevalonate tests, or serum methyl sterol determinations either before or during cholestyramine treatment in normolipidaemic control subjects, hyperlipidaemic (both hyper-glyceridaemic and hypercholesterolaemic) patients with normal liver function served as a control group for the cholestyramine experiments (Miettinen, 1971b) . Owing to obesity, some of these subjects exhibited high cholesterol production, the hypercholesterolaemic patients tending to have subnormal values.
CHEMICAL ANALYSES
Serum cholesterol (Pearson, Stern, and McGavack, 1953) and triglycerides (Carlson, 1963) were determined during basal faecal collections, non-esterified cholesterol being measured in connexion with quantification of methyl sterols (Miettinen, 1971b) . The latter was performed by GLC after the methyl sterols had been separated by thin-layer chromatography (TLC) from the other lipid classes (including free cholesterol) in the chloroform methanol extract of serum. The ratio 14C/3H of the acetate-mevalonate test was measured from the total serum cholesterol in the non-saponifiable material (Miettinen, 1970 (Miettinen, , 1971b . Faecal bile acids, neutral steroids, and dietary sterols were analysed by GLC Miettinen, Ahrens, and Grundy, 1965) , faecal fat according to the methods of van de Kamer, ten Bokkel Huinink, and Weyers (1949) , and chromium as suggested by Bolin, King, and Klosterman (1952) . Since no loss of ,B-sitosterol was found during intestinal transit (recovery of dietary plus administered ,-sitosterol in the faeces was complete in every case) the faecal values are expressed in terms of Cr2O3. For this purpose the amount of steroid or fat per mg of Cr203 in the faeces was multipled by 600. Urinary bile acids were measured in essentially the same way as in the faeces, except that they were solvolysed before alkaline hydrolysis (Palmer, 1967) and that a 1 % NGS (neopentyl glycol succinate) column was used for GLC analysis instead of the DC-560 column employed for the quantification of total faecal bile acids. Identification of urinary cholic acid, deoxycholic acid, chenodeoxycholic acid, and lithocholic acid depended on identity of the retention times of the trimethyl silyl derivatives of these bile acids with those of the references in the GLC run, and on mass spectrometry in a combined gas chromatography-mass spectrometry instrument (LKB-9 000) equipped with a 1 % NGS column (Miettinen and Luukkainen, 1968) .
Results
FAECAL FAT
As compared with the control subjects patients with liver diseases had increased excretion of faecal fat (Table II) . Faecal fat was not significantly higher in T. A. Miettinen the patients with raised than with normal alkaline phosphatase levels.
FAECAL STEROIDS
The amounts of faecal bile salts and neutral sterols were low in the patients with liver diseases (Table  II) . Since urinary bile salts (Tables II and III) contributed relatively little to bile salt excretion it can be concluded that in cirrhotic patients, especially in those with high alkaline phosphatase, bile acid synthesis is significantly reduced. Patient 7, with advanced but compensated cirrhosis, had a surprisingly high faecal and urinary bile acid output and low serum cholesterol; the other patients with normal alkaline phosphatase had quite low faecal bile salt values.
Faecal bile acids showed a positive correlation with neutral sterols (r = 0.52) under basal conditions but tended to be negatively correlated with faecal fat (r = -049; significant on log-log scale, r = -0.73) which in turn was negatively correlated with basal faecal neutral sterols (r = -0.57). Thus, it seems likely that under these basal conditions (low dietary cholesterol) the amount of faecal neutral sterols is determined mainly by the magnitude of biliary secretion of cholesterol, defective absorption, indicated by slightly impaired fat absorption, being a contributory factor.
URINARY BILE ACIDS
In normal urine only negligible amounts of bile acids (< 2 mg/day) were detected, the secondary bile acids (deoxycholic and lithocholic) comprising more than half, and cholic and deoxycholic acids about half of the total (Table III) . In patients with liver disease urinary excretion of bile acids was markedly increased (Tables II and III) , the proportion of secondary bile acids being subnormal. The sum of lithocholic and chenodeoxycholic acids (the former is formed from the latter by intestinal bacteria) comprised 50% or more of the total bile acids in six out of eight patients and in three out of eight controls. There was no correlation between urinary bile salts and serum alkaline phosphatase. The largest amount (33.6 mg/day) was seen in the patient (no. 7) who had the highest faecal loss of bile acids without detectable signs of biliary obstruction.
SERUM CHOLESTEROL
The low mean sterol balance value of the patients indicates that cholesterol synthesis (and elimination) was subnormal in liver cirrhosis (Table II) . Serum cholesterol (Table I) Change -4-7 ± 24 -1.9 ± 1.9 -5.9 ± 21 -0.9 ± 0.3 -13.4 ± 4-6 Table If. group.bmj.com on June 23, 2017 -Published by http://gut.bmj.com/ Downloaded from indicating that the production and elimination of cholesterol were not always decreased proportionately. In case 7 excessively increased elimination of cholesterol into faeces primarily as bile acids (Table I1) was not sufficiently offset by enhanced production, resulting in low serum cholesterol. No correlation was found between the serum cholesterol and sterol balance values.
EFFECTS OF CHOLESTYRAMINE
In the patients the resin increased the faecal bile acids (Table IV) subnormally, by 210 mg/day as compared with 957 mg/day in the controls, indicating that the capacity of cirrhotic patients to produce bile acids is limited. This is caused initially by impaired synthesis and/or excretion of bile acids. In the patients with liver diseases, in contrast to the controls, cholestyramine consistently raised faecal neutral sterols, but, despite the increase, the total elimination (sum of faecal neutral and acidic steroids) was clearly below normal. A positive correlation (r = 0.75) was found between the increments of faecal bile acids and neutral sterols (Fig. 1) . Despite the apparent decrease in cholesterol absorption induced by the resin, fat absorption was not consistently altered, as indicated by the insignificant increase in faecal fat; the latter was raised, however, in six out of seven studies (Fig. 1) . Patient no. 7, in whom faecal bile acids were initially increased and who presented with diarrhoea, ceased to suffer from this symptom when given cholestyramine. Yet the latter had virtually no effect on the sum of his faecal plus urinary bile acids, because the production of bile acids was apparently maximally stimulated by interruption of the enterohepatic circulation of bile acids.
Treatment with the resin reduced urinary bile acids by factors of 2 and 3 in the controls and patients, respectively, yet normal values were not reached in the latter. In the controls reduction was -17 ± 2' +18 ± 3' +14 ± 2' +14 ± 2' +15 ± 32 +11 ± 32 +26 52 +116 302 Cirrhotic patients (4) None 50 ± 7' 8 ± 1 7 ± 2 7 ± 2 8 ± 2 8 ± 2 12± 2' 72 9 Resin 44 ± 5 9 ± 2 8 ± 2 8 ± 2 9 ± 1 8 ± 1 16 2 89 10 Change -6 ± 3' + 2 ± 1' +1 ± 3' +1 ± l' +1 ± 13 0 ± 2' +4 ± 1".' +17 ± 9' Table V Effect of cholestyramine on serum cholesterol and cholesterol synthesis in control subjects and in patients with liver diseases
Number of patients in parentheses. 'Hours after iv injection of a "4C-acetate-'H-mevalonate mixture. Statistically significant changes (p < 0O05) indicated by ' and differences from controls by '. The acetate-mevalonate test was performed in cases 7, 11, 14, and 15; methyl sterols were measured in all cholestyramine-treated patients; V = diunsaturated dimethylsterol; total methyl sterols are the sum of five subfractions found in the serum methyl sterol mixture by GLC; FCH = free cholesterol.
response to cholestyramine, though in the controls a threefold increase was seen in the ratio 14C/3H, suggesting that the production of cholesterol was enhanced between acetate and mevalonate by a factor of 3 (Table V) . The initial methyl sterol levels were significantly lower in the patients than in the controls, the increase during cholestyramine also being significantly lower in the former than in the latter, as if synthesis of cholesterol had been relatively little stimulated by the resin in the patients with liver diseases as compared with the controls.
Discussion
FAT AND STEROL ABSORPTION Micellar solubilization of the hydrolysis products of triglycerides with the aid of bile acids greatly promotes but is not essential for their absorption (Hofmann and Borgstrom, 1964; Hofmann, 1966; Morgan and Borgstrom, 1969) . However, absorption of cholesterol requires the presence of bile acids (Siperstein, Chaikoff, and Reinhardt, 1952) . Therefore, in view of the low intestinal bile salt concentration in patients with liver cirrhosis during fat digestion (Badley et al, 1970; Siurala, 1967, 1971 ) increases in faecal fats, and especially in neutral sterols, are to be expected. Fat loss, which was negatively correlated with faecal bile acids (and ultimately with synthesis of bile acids, because they are only present in small amounts in urine), was actually slightly increased but, even in case 13, in which biliary occlusion was apparently complete, it was only moderate, indicating that relatively large amounts of dietary fats had been absorbed. Administration of cholestyramine, which presumably further reduced the effective intraluminal bile salt concentration, did not consistently increase faecal fat, further strengthening the view that at least at a relatively low level of fat intake fat absorption proceeds quite effectively, provided pancreatic function and the intestinal mucosa are intact. Pancreatic insufficiency has been suggested to contribute to the steatorrhoea of liver cirrhosis by impairing lipolysis, while mucosal damage is rarely seen (cf Losowsky and Walker, 1969) . Complete exclusion of bile flow usually causes only moderately reduced fat absorption in man (Porter, Saunders, Tytgat, Brunser, and Rubin, 1971) or experimental animals (Shapiro, Koster, Rittenberg, and Schoenheimer, 1936; Morgan and Borgstrom, 1969) . In clinical biliary obstruction fat absorption ranges from 45 to 90% (Atkinson, Nordin, and Sherlock, 1956 ).
Cholesterol absorption has not been istudied in patients with liver cirrhosis. Since the diet given to the patients of the present study was quite low in cholesterol, most of the faecal neutral sterols must have originated from the bile or intestinal mucosa. The amount eliminated by the mucosa is unknown, particularly because mucosal synthesis of cholesterol is increased in the absence of bile (Dietschy and Gamel, 1971) . Patients with complete biliary occlusion, although they apparently do not absorb sterols, continue to excrete some endogenous cholesterol into the faeces (case 13; Norman and Strandvik, 1971) , presumably due to mucosal elimination. The biliary output of cholesterol may thus have been markedly decreased (Miettinen and Siurala, 1971) which would explain why the faecal loss of neutral sterols was subnormal in the present study even though absorption of both dietary and endogenous cholesterol was reduced. The increase of faecal neutral sterols in patients on cholestyramine was apparently caused by markedly decreased reabsorption of cholesterol due to impaired micelle formation, particularly because interruption of enterohepatic circulation of bile acids by cholestyramine may have decreased the bile aciddependent biliary secretion of cholesterol (Schersten, Nilsson, Cahlin, Filipson, and Brodin-Persson, 1971) . Increased elimination by the mucosa is not excluded, however. Since faecal fat was not significantly increased by the resin, a reduction in lipid absorption which is dependent on micelle formation seems to be more clearly evidenced by faecal sterols than by fat.
BILE ACID METABOLISM
Earlier studies, recording quantitatively normal biliary secretion of bile acids after the administration of secretin and pancreozymin/cholecystokinin, have suggested that bile acid synthesis was not decreased in patients with liver cirrhosis (Turnberg and Grahame, 1970; Bode et al, 1971) . In the present series, however, combined faecal and urinary loss of bile salts under basal conditions and on cholestyramine clearly showed that bile salt production and capacity to augment bile acid synthesis are decreased in liver cirrhosis. In one case raised basal excretion of bile salts was associated with cholestyramine-suppressible diarrhoea, suggesting that the diarrhoea occasionally found in cirrhotic patients may be cholerrhoeic diarrhoea. Interrupted enterohepatic circulation of bile acids in this case is apparently caused by ileal dysfunction, the aetiology of which remains unknown. Though mucosal damage is infrequently seen in the upper small intestine (cf Losowsky and Walker, 1969) its presence in the ileum of this case is not excluded. Increased portal pressure and enhanced intestinal motility could also impair reabsorption of bile acids. Rapid intestinal transit, induced by oral mannitol, has been reported to cause slight bile salt malabsorption (Meihoff and Kern, 1968) .
According to earlier studies, bile salts are not present in normal urine, and are not consistently detectable in the urine of cirrhotic patients, biliary occlusion markedly increasing their excretion by this route (Rudman and Kendall, 1957; Gregg, 1968; Norman and Strandvik, 1971) . In the present series urinary bile salts were always higher in the patients with cirrhosis than in the normal subjects, and appeared to be very sensitive indicators of impaired parenchymal cell function and/or biliary obstruction. The relative increase in the amount of chenodeoxycholic (plus lithocholic) acid, earlier reported in the urine, serum, and bile of cirrhotic subjects (Rudman and Kendall, 1957; Carey, 1958; Sjovall, 1960; Gregg, 1968) , was frequently but not constantly seen in the urinary bile acids of the present series. Enhanced release of newly synthesized primary bile acids from the liver into the blood, and relatively low absorption of secondary bile acids from the intestine (due to a marked reduction in primary bile acids escaping during each enterohepatic circulation into the colon for conversion to secondary products by colonic bacteria) may explain the low percentage of secondary bile acids in the urine of cirrhotic subjects. (Miettinen, 1970 (Miettinen, ,1971b 
